Flestolol
- Level
- Commodity
- Parent
- 51263100
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51263142This classification denotes a beta-adrenergic blocking agent with the molecular formula C15H22FN3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LI02075E1W, chemically known as [3-[[1-(carbamoylamino)-2-methylpropan-2-yl]amino]-2-hydroxypropyl]2-fluorobenzoate but generally known as flestolol, which bears US NIH Compound Identifier 55885. European Medicines Agency schedules flestolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07641MIG. Most nations schedule flestolol under HS 29242190 and SITC 51473. As of Q4 2014, FLESTOLOL remains the US FDA Preferred Term for this commodity. Flestolol bears US NLM identifiers UMLS ID C0060455 and NCI Concept Code C72784. SMILES: CC(C)(CNC(=O)N)NCC(COC(=O)C1=CC=CC=C1F)O.
Same parent
Under 51263100 · 75Activities that produce or sell this
KBLI · 8Inherited from family 51260000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.